紐約一線醫生的新冠更新（ March 12, 2022）

 

也許，對亞洲的朋友們有借鑒，祝大家平安。

 

 

In COVID-19 clinical update #105, Daniel Griffin discusses changes in brain structure after infection, dementia in patients with pneumonia, Paxlovid in children, mask effectiveness in schools, host factors and severe disease, post-acute symptoms, and the mission of CEPI.

 

 

 

Links for this episode

• Infection and changes in brain structure (Nature)
• Dementia among pneumonia survivors (Open Forum Inf Dis)
• Narrative dynamics around COVID-19 vaccines (FSI)
• Children and COVID (AAP)
• Paxlovid in pediatric patients (Pfizer)
• Mask effectiveness in schools (MMWR)
• Host factors and severe disease (Nature)
• Antiviral efficacy against BA.2 (NEJM)
• Post-acute symptoms, Denmark (medRxiv)
• Risk of sequelae after infection (BMJ)
• CEPI (TWiV 612)
• Contribute to ASTMH fundraiser at PWB
• Letters read on TWiV 874